Biophilia Tracker for Pancreatic Diseases

MSCT is required when the Biophilia Tracker cannot clearly visualize certain areas of the pancreas or hypothetical volumic processes within the pancreas.

MSCT was used in all 30 patients (100%) to characterize pancreatic diseases. Based on the data obtained, in the absence of pancreatic size increase, MSCT provides less information compared to 3D reconstruction because it cannot provide clear information about substantial changes when the radiometric density of pancreatic tissue is close to normal.

MSCT offers the possibility of diagnosing exacerbations of pancreatitis: calcification, pseudocyst formation, involvement of surrounding organs, or pancreatic parenchymal atrophy. This method allows for the assessment of soft tissue effects beyond the pancreas and surrounding structures to evaluate the prevalence of processes and inflammatory responses in the parapancreatic tissues and retroperitoneal space. However, sometimes fibrosis and inflammatory changes may mimic tumor invasion.

The disadvantage of this diagnostic method is its high cost. Another disadvantage is the strict binding of the acquired images to the transverse plane.

The Biophilia Tracker is effective in diagnosing many diseases and can save you significant costs.